Evidence map›Paper›PMID 22941214›Full record

ReviewIndian journal of pediatrics2013

Rheumatic heart disease: progress and challenges in India.

Bela Shah, Meenakshi Sharma, Rajesh Kumar, K N Brahmadathan, Vinod Joseph Abraham, Rajan Tandon

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A ping-pong ball in left atrium.BMJ case reports · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Professor Rajendra Tandon: Passing of a legend.Annals of pediatric cardiology · 2014
    Article
  15. Article
  16. Article
  17. Rheumatic fever & rheumatic heart disease: the last 50 years.The Indian journal of medical research · 2013
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Bela ShahDivision of Non Communicable Diseases, Indian Council of Medical Research, Ansari Nagar, New Delhi, 110029, India.
Meenakshi Sharma
Rajesh Kumar
K N Brahmadathan
Vinod Joseph Abraham
Rajan Tandon
Christian Medical College & Hospital · INIndian Council of Medical Research · INPost Graduate Institute of Medical Education and Research · INSitaram Bhartia Institute of Science and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatic heart disease, a neglected disease, continues to be a burden in India and other developing countries. It is a result of an autoimmune sequalae in response to group A beta hemolytic streptococcus (GAS) infection of the pharynx. Acute rheumatic fever (RF), a multisystem inflammatory disease, is followed by rheumatic heart disease (RHD) and has manifestations of joints, skin and central nervous system involvement. A review of epidemiological studies indicates unchanged GAS pharyngitis and carrier rates in India. The apparent decline in RHD rates in India as indicated by the epidemiological studies has to be taken with caution as methodological differences exist among studies. Use of echocardiography increases case detection rates of RHD in population surveys. However, the significance of echo based diagnosis of carditis needs further evaluation to establish the significance. Research in this area through prospective follow up studies will have to be undertaken by the developing countries as the interest of developed countries in the disease has waned due the declined burden in their populations. Prevention of RHD is possible through treatment of GAS pharyngitis (primary prophylaxis) and continued antibiotic treatment for number of years in patients with history of RF to prevent recurrences (secondary prophylaxis). The cost effectiveness and practicality of secondary prophylaxis is well documented. The challenge to any secondary prophylaxis program for prevention of RF in India will be the availability of benzathine penicillin G and dissipation of fears of allergic reactions to penicillin among practitioners, general public and policy makers. The authors review here the progress and challenges in epidemiology, diagnosis and primary and secondary prevention of RF and RHD.

Indexed as

Developing CountriesAnti-Bacterial AgentsChildEarly DiagnosisHumansIndiaLong-Term CareNeglected DiseasesPenicillin G BenzathinePharyngitisPractice Guidelines as TopicRheumatic FeverRheumatic Heart DiseaseSecondary PreventionStreptococcal InfectionsStreptococcus pyogenesAnti-Bacterial AgentsPenicillin G Benzathine

Identifiers

PMID22941214
OpenAlexW2003915401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.